Careium AB (FRA:I81) Other Stockholders Equity: €65.42 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:I81 Careium AB FRA:I81
84 GF Score
Price €2.59
GF Value €2.52
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Careium AB Other Stockholders Equity?

Careium AB FRA:I81 -1.15% 84 Other Stockholders Equity is €65.42 Mil as of Jun. 2026. GuruFocus rates FRA:I81 with a GF Score™ of 84/100 and a GF Value™ of €2.52 (Fairly Valued). The stock has 6 warning signs investors should review.

Careium AB's Other Stockholders Equity for the quarter that ended in Jun. 2026 was €65.42 Mil.

Careium AB's quarterly Other Stockholders Equity increased from Dec. 2025 (€0.41 Mil) to Mar. 2026 (€64.85 Mil) and increased from Mar. 2026 (€64.85 Mil) to Jun. 2026 (€65.42 Mil).

Careium AB's annual Other Stockholders Equity increased from Dec. 2023 (€1.91 Mil) to Dec. 2024 (€3.34 Mil) but then declined from Dec. 2024 (€3.34 Mil) to Dec. 2025 (€0.41 Mil).

Careium AB Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Careium AB's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Careium AB Other Stockholders Equity Chart

Careium AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial 0.54 2.66 1.91 3.34 0.41

Careium AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 61.25 61.59 0.41 64.85 65.42
FRA:I81
84GF Score
Careium AB FRA:I81
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Careium AB Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €65.42 Mil mean?
Careium AB (FRA:I81) has a Other Stockholders Equity of €65.42 Mil as of Jun. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Careium AB and its competitors.
Is Careium AB's Other Stockholders Equity too high?
Careium AB's current Other Stockholders Equity is €65.42 Mil. Overall, Careium AB has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Careium AB's Other Stockholders Equity compare to ALLE and MSA?
Careium AB's Other Stockholders Equity of €65.42 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Business Services company?
A good Other Stockholders Equity depends on the Business Services industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Careium AB and its competitors. Careium AB's current Other Stockholders Equity is €65.42 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Careium AB stock overvalued right now?
Based on GuruFocus' analysis, Careium AB (FRA:I81) is currently considered Fairly Valued. The stock's GF Value™ is €2.52, compared to a current price of €2.59 — trading 2.8% above its estimated fair value. The current Other Stockholders Equity is €65.42 Mil. Careium AB's overall GF Score™ is 84/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Careium AB (FRA:I81), the current Other Stockholders Equity is €65.42 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Careium AB (FRA:I81) Overvalued in 2026?

Based on GuruFocus' analysis, Careium AB stock appears to be overvalued. The current stock price of €2.59 is trading 2.8% above its estimated GF Value™ of €2.52. GuruFocus considers Careium AB to be Fairly Valued.

Key valuation signals for FRA:I81:

  • Other Stockholders Equity: €65.42 Mil
  • GF Value™: €2.52 vs. price of €2.59 (2.8% above fair value)
  • GF Score™: 84/100 with 6 warning signs

No single metric tells the full story. See the FRA:I81 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Careium AB Business Description

Other Exchanges CARE:Sweden
Address Jorgen Kocksgatan 1B, Malmo, SWE, 211 20
Careium AB is a player in technology-enabled care in Sweden which provides solutions to improve the safety, quality of life, and independence of seniors both inside and outside the home. It offers a complete digital alarm chain. Its product catalog includes security alarms, fall sensors, smoke detectors motion detectors, accessories such as cameras, electronic locks, robotic medication assistive devices, and secure communication with alarm response. Geographically it has a presence in Nordics, the United Kingdom and Ireland, Central Europe, and Other markets, Its majority of the revenue comes from Nordics.
84GF Score

Get the complete analysis for FRA:I81

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.59
Price
€2.52
GF Value